These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12450574)

  • 1. Enzymological and pharmacological profile of T-0156, a potent and selective phosphodiesterase type 5 inhibitor.
    Mochida H; Takagi M; Inoue H; Noto T; Yano K; Fujishige K; Sasaki T; Yuasa K; Kotera J; Omori K; Kikkawa K
    Eur J Pharmacol; 2002 Dec; 456(1-3):91-8. PubMed ID: 12450574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-0156, a novel phosphodiesterase type 5 inhibitor, and sildenafil have different pharmacological effects on penile tumescence and electroretinogram in dogs.
    Mochida H; Noto T; Inoue H; Yano K; Kikkawa K
    Eur J Pharmacol; 2004 Feb; 485(1-3):283-8. PubMed ID: 14757152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FR226807: a potent and selective phosphodiesterase type 5 inhibitor.
    Hosogai N; Hamada K; Tomita M; Nagashima A; Takahashi T; Sekizawa T; Mizutani T; Urano Y; Kuroda A; Sawada K; Ozaki T; Seki J; Goto T
    Eur J Pharmacol; 2001 Oct; 428(2):295-302. PubMed ID: 11675048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
    Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
    Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159.
    Doh H; Shin CY; Son M; Ko JI; Yoo M; Kim SH; Kim WB
    Arch Pharm Res; 2002 Dec; 25(6):873-8. PubMed ID: 12510841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum.
    Takagi M; Mochida H; Noto T; Yano K; Inoue H; Ikeo T; Kikkawa K
    Eur J Pharmacol; 2001 Jan; 411(1-2):161-168. PubMed ID: 11137871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859.
    Qiu Y; Bhattacharjee S; Kraft P; John TM; Craig E; Haynes-Johnson D; Guan J; Jiang W; Macielag M; Sui Z; Clancy J; Lundeen S
    Eur J Pharmacol; 2003 Jul; 472(1-2):73-80. PubMed ID: 12860475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of penile tumescence by T-1032, a new potent and specific phosphodiesterase type V inhibitor, in dogs.
    Noto T; Inoue H; Ikeo T; Kikkawa K
    J Pharmacol Exp Ther; 2000 Sep; 294(3):870-5. PubMed ID: 10945835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.
    Chiu JH; Chen KK; Chien TM; Chiou WF; Chen CC; Wang JY; Lui WY; Wu CW
    Int J Impot Res; 2006; 18(4):335-42. PubMed ID: 16395327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.
    Mochida H; Inoue H; Takagi M; Noto T; Yano K; Kikkawa K
    Eur J Pharmacol; 2002 Apr; 440(1):45-52. PubMed ID: 11959087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
    Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
    Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum.
    Toque HA; Teixeira CE; Lorenzetti R; Okuyama CE; Antunes E; De Nucci G
    Eur J Pharmacol; 2008 Sep; 591(1-3):189-95. PubMed ID: 18593576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
    Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
    Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,7- and 2,7-naphthyridine derivatives as potent and highly specific PDE5 inhibitors.
    Ukita T; Nakamura Y; Kubo A; Yamamoto Y; Moritani Y; Saruta K; Higashijima T; Kotera J; Fujishige K; Takagi M; Kikkawa K; Omori K
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2341-5. PubMed ID: 12824030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5).
    Kotera J; Fujishige K; Michibata H; Yuasa K; Kubo A; Nakamura Y; Omori K
    Biochem Pharmacol; 2000 Nov; 60(9):1333-41. PubMed ID: 11008127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Lau DH; Thompson CS; Morgan RJ; Mumtaz FH; Mikhailidis DP
    BJU Int; 2005 Dec; 96(9):1424. PubMed ID: 16287475
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
    Delpy E; le Monnier de Gouville AC
    Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KMUP-1 relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: involvement of cyclic GMP and K(+) channels.
    Lin RJ; Wu BN; Lo YC; Shen KP; Lin YT; Huang CH; Chen IJ
    Br J Pharmacol; 2002 Mar; 135(5):1159-66. PubMed ID: 11877322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5.
    Hirose R; Okumura H; Yoshimatsu A; Irie J; Onoda Y; Nomoto Y; Takai H; Ohno T; Ichimura M
    Eur J Pharmacol; 2001 Nov; 431(1):17-24. PubMed ID: 11716838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changed phosphodiesterase selectivity and enhanced in vitro efficacy by selective deuteration of sildenafil.
    Schneider F; Mattern-Dogru E; Hillgenberg M; Alken RG
    Arzneimittelforschung; 2007; 57(6):293-8. PubMed ID: 17688073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.